SCHEMBL24933808

SCHEMBL24933808

NC(=O)c1cc(-c2ccc(OCc3cc(Cl)ccn3)cc2)c(C(F)(F)F)[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.39
DHODH Q02127 1/20 0.36
JAK2 O60674 2/20 0.35
HSD17B1 P14061 2/20 0.35
HSD17B2 P37059 2/20 0.35
PARP10 Q53GL7 1/20 0.35
CNR1 P21554 3/20 0.35
KDM4C Q9H3R0 1/20 0.35
CNR2 P34972 1/20 0.34
PRKAB2 O43741 1/20 0.33
PRKAG1 P54619 1/20 0.33
PRKAA2 P54646 1/20 0.33
PRKAA1 Q13131 1/20 0.33
PRKAG3 Q9UGI9 1/20 0.33
PRKAG2 Q9UGJ0 1/20 0.33
PRKAB1 Q9Y478 1/20 0.33
ALOX5AP P20292 1/20 0.33
MAPK14 Q16539 1/20 0.33
SMO Q99835 1/20 0.33
PARP1 P09874 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30240672 0.88 KDM4E (0.38) DHODHHSD17B1HSD17B2CNR1KDM4C
SCHEMBL24932971 0.88 KDM4E (0.38) DHODHHSD17B1HSD17B2CNR1KDM4C
SCHEMBL30240777 0.87 PDE10A (0.39) PDE10ADHODHCNR1CNR2ALOX5AP
SCHEMBL24933803 0.87 PDE10A (0.39) PDE10ADHODHCNR1CNR2ALOX5AP
SCHEMBL30240779 0.87 PARP10 (0.51) PDE10ADHODHPARP10MAPK14SMO
SCHEMBL24933620 0.87 PARP10 (0.51) PDE10ADHODHPARP10MAPK14SMO
SCHEMBL30240711 0.86 SYK (0.42) PDE10ADHODHHSD17B1HSD17B2PARP10
SCHEMBL24933796 0.86 SYK (0.42) PDE10ADHODHHSD17B1HSD17B2PARP10
SCHEMBL24933841 0.84 HDAC1 (0.36) PDE10ADHODHJAK2HSD17B1HSD17B2
SCHEMBL24932918 0.84 DHODH (0.36) PDE10ADHODHHSD17B1HSD17B2KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed